Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Patrick O'Neill

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Neurology|February 26, 2004
Neurocognitive outcomes in primary CNS lymphoma (PCNSL)Brian Patrick O'Neill
Journal of Neuro-Oncology|November 3, 2011
Glioblastoma survival in the United States before and during the temozolomide eraDerek R Johnson, Brian Patrick O'Neill
The Neurologist|January 15, 2004
Brain metastasesKevin J Klos, Brian Patrick O'Neill
Neuro-Oncology|May 25, 2007
EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetilBrian Patrick O'Neill, Steven Vernino, Ahmet Dogan, et al.
American Journal of Hematology|July 23, 2013
The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphomaBrian Patrick O'Neill, Paul A Decker, Christina Tieu, et al.
Neurosurgical Focus|December 1, 2006
Ocular manifestations and treatment of central nervous system lymphomasKaan Gündüz, Jose S Pulido, Colin A McCannel, et al.
Neuro-Oncology|June 21, 2014
Second malignancies in patients with primary central nervous system lymphomaJun Wang, Jose S Pulido, Brian Patrick O'Neill, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2006
Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51Nadia N Laack, Karla V Ballman, Paul B Brown, et al.
Neuro-Oncology|February 11, 2004
Immunomodulatory treatment trial for paraneoplastic neurological disordersSteven Vernino, Brian Patrick O'Neill, Randolph S Marks, et al.
Neuro-Oncology|April 18, 2012
Early measures of cognitive function predict survival in patients with newly diagnosed glioblastomaDerek R Johnson, Allison M Sawyer, Christina A Meyers, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Neurology|February 26, 2004
Neurocognitive outcomes in primary CNS lymphoma (PCNSL)Brian Patrick O'Neill
Journal of Neuro-Oncology|November 3, 2011
Glioblastoma survival in the United States before and during the temozolomide eraDerek R Johnson, Brian Patrick O'Neill
The Neurologist|January 15, 2004
Brain metastasesKevin J Klos, Brian Patrick O'Neill
Neuro-Oncology|May 25, 2007
EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetilBrian Patrick O'Neill, Steven Vernino, Ahmet Dogan, et al.
American Journal of Hematology|July 23, 2013
The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphomaBrian Patrick O'Neill, Paul A Decker, Christina Tieu, et al.
Neurosurgical Focus|December 1, 2006
Ocular manifestations and treatment of central nervous system lymphomasKaan Gündüz, Jose S Pulido, Colin A McCannel, et al.
Neuro-Oncology|June 21, 2014
Second malignancies in patients with primary central nervous system lymphomaJun Wang, Jose S Pulido, Brian Patrick O'Neill, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2006
Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51Nadia N Laack, Karla V Ballman, Paul B Brown, et al.
Neuro-Oncology|February 11, 2004
Immunomodulatory treatment trial for paraneoplastic neurological disordersSteven Vernino, Brian Patrick O'Neill, Randolph S Marks, et al.
Neuro-Oncology|April 18, 2012
Early measures of cognitive function predict survival in patients with newly diagnosed glioblastomaDerek R Johnson, Allison M Sawyer, Christina A Meyers, et al.
Pageof 4